Latest / WTR Small-Cap Spotlight
The lure of the NASDAQ for Biotechs
Send us Fan Mail
In this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.